Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

portable Artificial Pancreas

The artificial pancreas system will be allowed to employ its Model Predictive Control algorithm to make decisions about insulin delivery based on measured glucose levels.

Trial Locations (1)

93105

Sansum Diabetes Research Institutute, Santa Barbara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Virginia

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of California, Santa Barbara

OTHER

collaborator

University of Padova

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT01929798 - Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin | Biotech Hunter | Biotech Hunter